首页> 美国政府科技报告 >Evaluation in Rhesus Monkeys of a Bivalent Live Attenuated Dengue Vaccine Containing Types 2 and 4 Viruses
【24h】

Evaluation in Rhesus Monkeys of a Bivalent Live Attenuated Dengue Vaccine Containing Types 2 and 4 Viruses

机译:含有2型和4型病毒的二价减毒登革热疫苗对恒河猴的评价

获取原文

摘要

The purpose of this study was to determine whether a bivalent (dengue-2-4) vaccine could confer immunity in rhesus monkeys against wild type virus infection. It was found that: (1) DEN-2/S-1 animals showed an anamnestic response as well as undetectable viremia after challenge with w.t. DEN-2 virus. Divalent vaccines also showed an anamnestic response after DEN-2 virus challenge. (2) DEN-4 vaccine did not elicit a measurable immune response in 6/8 animals as judged by PRNT, augmented N tests and by DEN-2 challenge experiments. An anamnestic response was observed in 2/8 animals. (3) N antibody levels of most of the vaccinated animals declined markedly on or before post vaccination day 150. (4) Viral interference among the two different vaccine serotypes could not be demonstrated.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号